BBA
WST icon

Braun-Bostich & Associates’s West Pharmaceutical WST Stock Holding History

Braun-Bostich & Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-755
Closed -$266K – 133
2023
Q4 		$266K Sell
755
-7
-0.9% -$2.48K 0.24% 103
2023
Q3 		$286K Buy
+762
New +$295K 0.53% 33
2020
Q4 		– Sell
-1,028
Closed -$283K – 229
2020
Q3 		$283K Buy
1,028
+1,003
+4,012% +$265K 0.28% 53
2020
Q2 		$6K Buy
+25
New +$4.91K 0.01% 258

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Braun-Bostich & Associates's WST Position: Q1 2024 in Review

Braun-Bostich & Associates sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 755 shares — an estimated $266K sold.

Braun-Bostich & Associates first reported a position in WST in Q2 2020 and held it in 4 quarters. The position peaked at $286K in Q3 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Braun-Bostich & Associates reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Braun-Bostich & Associates sold 755 West Pharmaceutical shares in Q1 2024, an estimated $266K.
  • Braun-Bostich & Associates first reported a position in West Pharmaceutical in Q2 2020 and held it in 4 quarters.
  • Braun-Bostich & Associates's West Pharmaceutical position peaked at $286K in Q3 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Braun-Bostich & Associates's 13F filing for Q1 2024, filed 29 Apr 2024.